Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates

Saudi Medical Journal

Volumn 26, Issue 12, 2005, Pages 1914-1917

  Kader, Abdulrahman A ^a   Kumar, Angamuthu ^a   Krishna, Ananth ^a  

^a Almana General Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; METICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SAUDI ARABIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

CLINDAMYCIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS;

EID: 31844435141     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Srinvasan A, Dick JD, Perl TM. Vancomycin resistance in Staphylococci. Cli Microbiol Rev 2002; 15: 430-438.
2. Hamilton-Miller JMT, Shah S. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolidestreptogramin group of antibiotics in Staphylococci. J Antimicrob Chemother 2000; 46: 941-949.
3. Ross, JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wootton JC. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 1990; 4: 1207-1214.
4. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-492.
5. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H Nomenclature for macrolide-lincosamidestreptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823-2830.
6. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001; 48: 315-316.
7. Frank AL, Marcinak JF, Mahgat PD, Tjhio JT, Kelkar S, Schreckenberger PC, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21: 530-534.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Supplement M100-S14. Wayne (PA): NCCLS; 2004.
9. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37: 1257-1260.
10. Cowan SF, Steel KJ. Manual for identification of medical bacteria. 3rd ed. Cambridge: Cambridge University Press; 1993. p. 140-143.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M100-S13. Wayne (PA): NCCLS; 2003.
12. Sanchez ML, Flint KK, Jones RN. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem? Diagn Microbiol Infect Dis 1993; 16: 205-213.
13. Goyal R, Singh NP, Manchanda V, Mathur M. Detection of clindamycin susceptibility in macrolide resistant phenotypes of Staphylococcus aureus. Indian J Med Microbiol 2004; 22: 251-254.
14. Schreckenberger PC, Elizabeth I, Kathryn LR. Incidence of Constitutive and Inducible Clindamycin Resistance in Staphylococcus aureus and Coagulase-Negative Staphylococci in a Community and a Tertiary Care Hospital. J Clin Microbiol 2004; 42: 2777-2779.
15. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4744.
16. Watanakunakorn C. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am J Med 1976; 60: 419-425.
17. Tuazon CU, Sheagren JN. Relapse of staphylococcal endocarditis after clindamycin therapy. Am J Med Sci 1975; 269:145-148.
18. Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infections caused by erythromycin resistant staphylococci? J Antimicrob Chemother 1999; 44: 581-582.
19. Gopal Rao G. Should clindamycin be used in treatment of patients with infections caused by erythromycin resistant staphylococci? J Antimicrob Chemother 2000; 45: 715.
20. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure. Antimicrob Agents Chemother 2005; 49: 1222-1224.
21. Eady EA, Ross JI, Tipper JL, Walters CE, Cove JH, Noble WC. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of Staphylococci. J Antimicrob Chemother 1993; 31: 211-217.